These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34671892)

  • 1. Effect of a sodium restriction diet on albuminuria and blood pressure in diabetic kidney disease patients: a meta-analysis.
    Chen Y; Wang X; Jia Y; Zou M; Zhen Z; Xue Y
    Int Urol Nephrol; 2022 Jun; 54(6):1249-1260. PubMed ID: 34671892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered dietary salt intake for people with chronic kidney disease.
    McMahon EJ; Campbell KL; Bauer JD; Mudge DW
    Cochrane Database Syst Rev; 2015 Feb; (2):CD010070. PubMed ID: 25691262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Salt Restriction in Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials.
    Garofalo C; Borrelli S; Provenzano M; De Stefano T; Vita C; Chiodini P; Minutolo R; De Nicola L; Conte G
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29882800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered dietary salt intake for preventing and treating diabetic kidney disease.
    Suckling RJ; He FJ; Macgregor GA
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006763. PubMed ID: 21154374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Dietary Sodium Restriction in Kidney Transplant Recipients Treated With Renin-Angiotensin-Aldosterone System Blockade: A Randomized Clinical Trial.
    de Vries LV; Dobrowolski LC; van den Bosch JJ; Riphagen IJ; Krediet CT; Bemelman FJ; Bakker SJ; Navis G
    Am J Kidney Dis; 2016 Jun; 67(6):936-44. PubMed ID: 26803690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol.
    Keyzer CA; de Jong MA; Fenna van Breda G; Vervloet MG; Laverman GD; Hemmelder M; Janssen WM; Lambers Heerspink HJ; Navis G; de Borst MH;
    Nephrol Dial Transplant; 2016 Jul; 31(7):1081-7. PubMed ID: 25744274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance.
    Vedovato M; Lepore G; Coracina A; Dodesini AR; Jori E; Tiengo A; Del Prato S; Trevisan R
    Diabetologia; 2004 Feb; 47(2):300-3. PubMed ID: 14704836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials.
    He FJ; Li J; Macgregor GA
    BMJ; 2013 Apr; 346():f1325. PubMed ID: 23558162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of longer-term modest salt reduction on blood pressure.
    He FJ; Li J; Macgregor GA
    Cochrane Database Syst Rev; 2013 Apr; (4):CD004937. PubMed ID: 23633321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Behavioral Interventions for Salt Reduction on Blood Pressure and Urinary Sodium Excretion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Xun R; Gao Y; Zhen S; Mao T; Xia H; Zhang H; Sun G
    Glob Heart; 2023; 18(1):65. PubMed ID: 38143483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium sensitivity related to albuminuria appearing before hypertension in type 2 diabetic patients.
    Imanishi M; Yoshioka K; Okumura M; Konishi Y; Okada N; Morikawa T; Sato T; Tanaka S; Fujii S
    Diabetes Care; 2001 Jan; 24(1):111-6. PubMed ID: 11194215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-Analysis of the Effect of Dietary Sodium Restriction with or without Concomitant Renin-Angiotensin-Aldosterone System-Inhibiting Treatment on Albuminuria.
    D'Elia L; Rossi G; Schiano di Cola M; Savino I; Galletti F; Strazzullo P
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1542-52. PubMed ID: 26240299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.
    Parvanova A; Trillini M; Podestà MA; Iliev IP; Ruggiero B; Abbate M; Perna A; Peraro F; Diadei O; Rubis N; Gaspari F; Carrara F; Stucchi N; Belviso A; Bossi AC; Trevisan R; Remuzzi G; de Borst M; Ruggenenti P;
    Lancet Diabetes Endocrinol; 2018 Jan; 6(1):27-40. PubMed ID: 29104158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
    Allen TJ; Waldron MJ; Casley D; Jerums G; Cooper ME
    Diabetes; 1997 Jan; 46(1):19-24. PubMed ID: 8971091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial.
    Hwang JH; Chin HJ; Kim S; Kim DK; Kim S; Park JH; Shin SJ; Lee SH; Choi BS; Lim CS
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2059-69. PubMed ID: 25332317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advice to reduce dietary salt for prevention of cardiovascular disease.
    Hooper L; Bartlett C; Davey SG; Ebrahim S
    Cochrane Database Syst Rev; 2004; (1):CD003656. PubMed ID: 14974027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dietary salt for prevention of cardiovascular disease.
    Hooper L; Bartlett C; Davey Smith G; Ebrahim S
    Cochrane Database Syst Rev; 2003; (3):CD003656. PubMed ID: 12917977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced dietary salt for prevention of cardiovascular disease.
    Hooper L; Bartlett C; Davey SM; Ebrahim S
    Cochrane Database Syst Rev; 2003; (2):CD003656. PubMed ID: 12804482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced dietary salt for prevention of cardiovascular disease.
    Hooper L; Bartlett C; Davey SM; Ebrahim S
    Cochrane Database Syst Rev; 2003; (1):CD003656. PubMed ID: 12535482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E1 for preventing the progression of diabetic kidney disease.
    Wang H; Deng JL; Yue J; Li J; Hou YB
    Cochrane Database Syst Rev; 2010 May; (5):CD006872. PubMed ID: 20464745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.